Literature DB >> 11513599

Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction.

I Golani1, A Weizman, S Leschiner, I Spanier, N Eckstein, R Limor, J Yanai, K Maaser, H Scherübl, G Weisinger, M Gavish.   

Abstract

The peripheral benzodiazepine receptor (PBR) is composed of three subunits with molecular masses of 18, 30, and 32 kDa. Many physiological functions have been attributed to the PBR, including regulation of steroidogenesis. Furthermore, the PBR itself is under hormonal regulation. In the current study, we investigated the role of female gonadal sex hormones in the regulation of PBR expression in steroidogenic and nonsteroidogenic tissues. To accomplish this, adult female rats were pharmacologically castrated using chronic administration of the gonadotropin-releasing hormone agonist decapeptyl (triptorelin-D-Trp(6)-LHRH). Half of these rats received 17beta-estradiol as hormone replacement, while a control group received daily injections of vehicle only. We found that PBR binding capacity dropped by 40 and 48% in ovaries and adrenals, respectively, following decapeptyl administration, as opposed to no change in the kidney. This down-regulation of PBR densities was prevented by estradiol replacement. We did not find evidence for transcriptional, posttranscriptional, and translational mechanisms in this decapeptyl-induced down-regulation. In contrast, immunoprecipitation of the PBR complex, using antibodies against the 18- and 32-kDa subunits of the complex, demonstrated that there were changes in PBR subunit interactions, consistent with the down-regulation of PBR binding capacity. These findings represent a novel hormone-dependent posttranslational regulatory mechanism.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11513599     DOI: 10.1021/bi010431+

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

Review 1.  Regulation of translocator protein 18 kDa (TSPO) expression in health and disease states.

Authors:  Amani Batarseh; Vassilios Papadopoulos
Journal:  Mol Cell Endocrinol       Date:  2010-06-30       Impact factor: 4.102

2.  Two binding sites for [3H]PBR28 in human brain: implications for TSPO PET imaging of neuroinflammation.

Authors:  David R Owen; Owain W Howell; Sac-Pham Tang; Lisa A Wells; Idriss Bennacef; Mats Bergstrom; Roger N Gunn; Eugenii A Rabiner; Martin R Wilkins; Richard Reynolds; Paul M Matthews; Christine A Parker
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-28       Impact factor: 6.200

3.  Cloning and expression of the translocator protein (18 kDa), voltage-dependent anion channel, and diazepam binding inhibitor in the gonad of largemouth bass (Micropterus salmoides) across the reproductive cycle.

Authors:  Nicholas J Doperalski; Christopher J Martyniuk; Melinda S Prucha; Kevin J Kroll; Nancy D Denslow; David S Barber
Journal:  Gen Comp Endocrinol       Date:  2011-05-10       Impact factor: 2.822

Review 4.  VDAC activation by the 18 kDa translocator protein (TSPO), implications for apoptosis.

Authors:  Leo Veenman; Yulia Shandalov; Moshe Gavish
Journal:  J Bioenerg Biomembr       Date:  2008-06       Impact factor: 2.945

Review 5.  Cholesterol transport in steroid biosynthesis: role of protein-protein interactions and implications in disease states.

Authors:  Malena B Rone; Jinjiang Fan; Vassilios Papadopoulos
Journal:  Biochim Biophys Acta       Date:  2009-03-12

6.  Combined effect of G3139 and TSPO ligands on Ca(2+)-induced permeability transition in rat brain mitochondria.

Authors:  T Azarashvili; O Krestinina; Yu Baburina; I Odinokova; D Grachev; V Papadopoulos; V Akatov; J J Lemasters; G Reiser
Journal:  Arch Biochem Biophys       Date:  2015-10-20       Impact factor: 4.013

7.  VDAC1: from structure to cancer therapy.

Authors:  Varda Shoshan-Barmatz; Dario Mizrachi
Journal:  Front Oncol       Date:  2012-11-29       Impact factor: 6.244

8.  Radiosynthesis and in vivo evaluation of two imidazopyridineacetamides, [(11)C]CB184 and [ (11)C]CB190, as a PET tracer for 18 kDa translocator protein: direct comparison with [ (11)C](R)-PK11195.

Authors:  Kentaro Hatano; Katsuhiko Sekimata; Takashi Yamada; Junichiro Abe; Kengo Ito; Mikako Ogawa; Yasuhiro Magata; Jun Toyohara; Kiichi Ishiwata; Giovanni Biggio; Mariangela Serra; Valentino Laquintana; Nunzio Denora; Andrea Latrofa; Giuseppe Trapani; Gaetano Liso; Hiromi Suzuki; Makoto Sawada; Masahiko Nomura; Hiroshi Toyama
Journal:  Ann Nucl Med       Date:  2015-01-24       Impact factor: 2.668

9.  Quinazoline-based tricyclic compounds that regulate programmed cell death, induce neuronal differentiation, and are curative in animal models for excitotoxicity and hereditary brain disease.

Authors:  A Vainshtein; L Veenman; A Shterenberg; S Singh; A Masarwa; B Dutta; B Island; E Tsoglin; E Levin; S Leschiner; I Maniv; L Pe'er; I Otradnov; S Zubedat; S Aga-Mizrachi; A Weizman; A Avital; I Marek; M Gavish
Journal:  Cell Death Discov       Date:  2015-11-30

Review 10.  Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics.

Authors:  Varda Shoshan-Barmatz; Yakov Krelin; Anna Shteinfer-Kuzmine; Tasleem Arif
Journal:  Front Oncol       Date:  2017-07-31       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.